TherapeuticsMD (TXMD) News Today → Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector… (From InvestorPlace) (Ad) Free TXMD Stock Alerts $2.22 +0.09 (+4.23%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 5:58 AM | americanbankingnews.comTherapeuticsMD (NASDAQ:TXMD) Receives New Coverage from Analysts at StockNews.comMay 25, 2024 | americanbankingnews.comTherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.comMay 15, 2024 | finance.yahoo.comTherapeuticsMD, Inc. (TXMD) Stock Price, News, Quote & History - Yahoo FinanceMay 10, 2024 | investorplace.comTXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024May 10, 2024 | businesswire.comTherapeuticsMD Announces First Quarter 2024 Financial ResultsMarch 29, 2024 | businesswire.comTherapeuticsMD Announces Full Year 2023 Financial ResultsMarch 12, 2024 | msn.com25 Countries With Highest Abortion RatesMarch 10, 2024 | sg.finance.yahoo.comTherapeuticsMD, Inc. (TXMD) stock historical prices & data – Yahoo FinanceDecember 29, 2023 | morningstar.comTherapeuticsMD Inc TXMDNovember 15, 2023 | nasdaq.comDaily Markets: Today Brings Producer Prices, Retail Sales DataNovember 14, 2023 | marketwatch.comTherapeuticsMD to Consider Strategic AlternativesNovember 14, 2023 | msn.comTherapeuticsMD exploring strategic alternatives for companyNovember 14, 2023 | finance.yahoo.comTherapeuticsMD Announces Third Quarter 2023 Financial ResultsOctober 4, 2023 | bizjournals.comBoca Raton-based prescription service announces layoffs, says a third of workforce could be cutSeptember 20, 2023 | marketwatch.comTherapeuticsMD Inc. stock falls Wednesday, underperforms marketAugust 15, 2023 | marketwatch.comTherapeuticsMD Inc. stock outperforms market despite losses on the dayAugust 14, 2023 | finance.yahoo.comTherapeuticsMD Announces Second Quarter 2023 Financial ResultsAugust 9, 2023 | finance.yahoo.comMicron Biomedical Appoints Brian Bernick, MD as Chairman of Its Board of DirectorsJuly 5, 2023 | marketwatch.comTherapeuticsMD Inc. stock underperforms Wednesday when compared to competitorsJuly 4, 2023 | thestreet.comTherapeuticsMD Rejected by FDA, Delay Could Be FatalMay 23, 2023 | seekingalpha.comTherapeuticsMD: From Fallen And Forgotten To Cash CowMay 15, 2023 | finance.yahoo.comTherapeuticsMD Announces First Quarter 2023 Financial ResultsMay 10, 2023 | marketwatch.comTherapeuticsMD Inc. stock falls Tuesday, underperforms marketMay 10, 2023 | marketwatch.comTherapeuticsMD Inc. stock rises Wednesday, still underperforms marketMay 3, 2023 | marketwatch.comTherapeuticsMD Inc. stock falls Monday, underperforms marketApril 30, 2023 | marketwatch.comTherapeuticsMD Inc. stock underperforms Friday when compared to competitorsApril 23, 2023 | marketwatch.comTherapeuticsMD Inc. stock outperforms market on strong trading dayApril 14, 2023 | msn.comAll You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to BuyApril 7, 2023 | finance.yahoo.comTherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model TransitionMarch 13, 2023 | marketwatch.comTherapeuticsMD Inc. stock underperforms Monday when compared to competitorsJanuary 5, 2023 | bizjournals.comTheraputicsMD sells products rights for $153 millionJanuary 3, 2023 | finance.yahoo.comTherapeuticsMD Completes Transaction to License Its Products to Mayne PharmaDecember 26, 2022 | reuters.comTXMD.A - TherapeuticsMD Inc | Stock Price & Latest News | ReutersDecember 19, 2022 | bizjournals.comTechnology & Innovation Roundup: Company will cut 212 employees after failed buyoutDecember 16, 2022 | marketwatch.comTherapeuticsMD Inc. stock falls Thursday, underperforms marketDecember 15, 2022 | marketwatch.comTherapeuticsMD Inc. stock rises Wednesday, outperforms marketDecember 4, 2022 | finance.yahoo.comTherapeuticsMD Announces Definitive Agreements to License its Products to Mayne PharmaNovember 15, 2022 | finance.yahoo.comTherapeuticsMD Announces Third Quarter 2022 Financial ResultsNovember 15, 2022 | finance.yahoo.comTherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue EstimatesNovember 13, 2022 | finance.yahoo.comTherapeuticsMD, Inc. (TXMD) Stock Historical Prices & Data - Yahoo FinanceOctober 31, 2022 | finance.yahoo.comTherapeuticsMD Announces Additional $7 Million Private PlacementOctober 3, 2022 | bizjournals.comTherapeuticsMD receives $7M investment after merger plans unravel - South Florida Business Journal - The Business JournalsOctober 3, 2022 | finance.yahoo.comTherapeuticsMD receives $7M investment after merger plans unravelOctober 3, 2022 | seekingalpha.comTherapeuticsMD rannounces $7 million private placement - Seeking AlphaOctober 3, 2022 | marketscreener.comTHERAPEUTICSMD, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.comOctober 3, 2022 | businesswire.comTherapeuticsMD Announces $7 Million Private Placement - Business WireOctober 3, 2022 | finance.yahoo.comTherapeuticsMD Announces $7 Million Private PlacementSeptember 30, 2022 | marketwatch.comTherapeuticsMD Inc. stock outperforms market despite losses on the day - MarketWatchSeptember 17, 2022 | thestreet.comTherapeuticsMD (TXMD) Stock Surges on Successful Vaginal Atrophy Drug TrialSeptember 16, 2022 | finance.yahoo.comPrenatal Vitamin Supplements Market to record USD 230.86 Mn growth -- Driven by increasing number of gynecologists recommending prenatal vitamin supplements to expecting mothers - Yahoo Finance Get TherapeuticsMD News Delivered to You Automatically Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address “This will be one of the biggest revolutions ever.” - NVIDIA CEO (Ad)NVIDIA's CEO calls it the "next amazing revolution"... The Economist says its a "boon to humanity"... And Jeff Bezos is heavily invested in it. A new breakthrough tech could add up to $20 trillion to the U.S. economy. TXMD Media Mentions By Week TXMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TXMD News Sentiment▼0.720.78▲Average Medical News Sentiment TXMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TXMD Articles This Week▼30▲TXMD Articles Average Week Get TherapeuticsMD News Delivered to You Automatically Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bullfrog AI News Nephros News Ekso Bionics News Accelerate Diagnostics News BriaCell Therapeutics News Unity Biotechnology News Cumberland Pharmaceuticals News Iterum Therapeutics News OncoCyte News Lisata Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TXMD) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
